Shailesh Buha

Shailesh Buha currently serves as the Lead of Analytical Development at Lotus Pharmaceutical Co., Ltd since January 2023, providing analytical development support for complex generics across multiple international regulatory agencies. Prior experience includes serving as Head of Analytical Sciences at Gracure Pharmaceuticals Ltd., leading method characterization and validation for regulated solid and semi-solid dosage forms, and as Head of Analytical Research & Validations at Neopharma, which involved extensive analytical methods development for various global markets. Shailesh's career also includes positions at Torrent Pharmaceuticals Ltd., where responsibilities encompassed support for generic ANDAs and solid-state characterization, as well as a leadership role at Zydus Group, focusing on biopharmaceutics and NCE support. Shailesh obtained a Master of Science in Industrial Analytical Chemistry from Gujarat University.